Palatin Technologies (PTN)
(Delayed Data from AMEX)
$1.60 USD
+0.06 (3.90%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $1.62 +0.02 (1.25%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 28% (71 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.66 | 2.87 | 59.00 |
Year Ago Quarter Estimate | -0.63 | -5.36 | 50.37 |
Next Quarter Estimate | -0.67 | 7.43 | 60.00 |
Next Year Estimate | -0.66 | 29.71 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 6.72 | 13.60 | 20.73 |
Next Year | 72.03 | 12.40 | 13.55 |
Last 5 Years | -207.00 | 1.00 | 9.00 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 2.22 |
Price/Cash Flow (MRFY) | NA | 14.19 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -445.13% | -114.01% |
Return on Equity (TTM) | -583.06% | -46.54% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.